HCMV spread and cell tropism are determined by distinct virus populations.
Human cytomegalovirus (HCMV) can infect many different cell types in vivo. Two gH/gL complexes are used for entry into cells. gH/gL/pUL(128,130,131A) shows no selectivity for its host cell, whereas formation of a gH/gL/gO complex only restricts the tropism mainly to fibroblasts. Here, we describe that depending on the cell type in which virus replication takes place, virus carrying the gH/gL/pUL(128,130,131A) complex is either released or retained cell-associated. We observed that virus spread in fibroblast cultures was predominantly supernatant-driven, whereas spread in endothelial cell (EC) cultures was predominantly focal. This was due to properties of virus released from fibroblasts and EC. Fibroblasts released virus which could infect both fibroblasts and EC. In contrast, EC released virus which readily infected fibroblasts, but was barely able to infect EC. The EC infection capacities of virus released from fibroblasts or EC correlated with respectively high or low amounts of gH/gL/pUL(128,130,131A) in virus particles. Moreover, we found that focal spread in EC cultures could be attributed to EC-tropic virus tightly associated with EC and not released into the supernatant. Preincubation of fibroblast-derived virus progeny with EC or beads coated with pUL131A-specific antibodies depleted the fraction that could infect EC, and left a fraction that could predominantly infect fibroblasts. These data strongly suggest that HCMV progeny is composed of distinct virus populations. EC specifically retain the EC-tropic population, whereas fibroblasts release EC-tropic and non EC-tropic virus. Our findings offer completely new views on how HCMV spread may be controlled by its host cells.
Max von Pettenkofer-Institut für Virologie, Ludwig-Maximilians-Universität München, München, Germany.
Laura
L
Scrivano
Christian
C
Sinzger
Hans
H
Nitschko
Ulrich H
UH
Koszinowski
Barbara
B
Adler
D001483:Base Sequence; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000472:pathogenicity / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000821:virology*; D004730:Endothelium, Vascular / Q000378:metabolism / Q000821:virology*; D005347:Fibroblasts / Q000378:metabolism / Q000821:virology*; D052816:Foreskin / Q000166:cytology; D054884:Host-Pathogen Interactions; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D014764:Viral Proteins / Q000378:metabolism; D056189:Viral Tropism / Q000502:physiology*; D053586:Virus Internalization; D014779:Virus Replication / Q000502:physiology
D014764:Viral Proteins
PLoS One. 2008 Mar 19;3(3):e1808
18350146
J Virol. 1992 Aug;66(8):4834-8
1321272
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7065-70
16606841
Nature. 2008 Sep 18;455(7211):391-5
18701889
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20037-42
18077432
Trends Cell Biol. 2004 Jan;14(1):5-8
14729174
J Virol. 2000 Dec;74(24):11881-92
11090188
Nat Med. 2002 Jun;8(6):594-9
12042810
J Clin Virol. 2006 Sep;37(1):10-20
16815742
Nat Med. 2005 May;11(5):515-21
15834425
Exp Cell Res. 2002 Feb 1;273(1):21-33
11795943
J Virol. 2006 Jan;80(2):710-22
16378974
J Virol. 1996 Aug;70(8):5557-63
8764069
J Virol. 2008 Jan;82(1):60-70
17942555
J Virol. 1992 Jun;66(6):3409-14
1316456
J Clin Microbiol. 2002 Jan;40(1):233-8
11773121
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2598-607
10509655
J Virol. 2010 Mar;84(5):2597-609
20032193
J Gen Virol. 2008 Feb;89(Pt 2):359-368
18198366
J Virol. 2004 Aug;78(15):7969-83
15254169
Virology. 1984 Jun;135(2):369-78
6330979
J Virol. 2007 Aug;81(15):7825-32
17459936
J Virol. 2009 Apr;83(8):3891-903
19193805
J Virol. 2010 Mar;84(5):2585-96
20032184
J Virol. 2010 Jan;84(2):1005-13
19889756
J Gen Virol. 1999 Nov;80 ( Pt 11):2867-2877
10580048
J Gen Virol. 2005 Feb;86(Pt 2):275-284
15659746
J Virol. 2005 Aug;79(16):10330-8
16051825
J Virol. 2010 Sep;84(18):9019-26
20592093
J Virol. 2010 May;84(9):4469-80
20181688
Gene. 1995 May 26;158(1):9-14
7789817
J Virol. 2005 Jun;79(12):7827-37
15919936
J Virol. 1997 Dec;71(12):9803-7
9371650
J Virol. 1997 Apr;71(4):3090-7
9060671
J Virol. 2008 Mar;82(6):2802-12
18184717
J Virol. 2004 Sep;78(18):10023-33
15331735
J Virol. 2004 Oct;78(20):10960-6
15452216
J Virol. 2004 Aug;78(15):8026-35
15254174
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18153-8
16319222
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20464-9
19920174
Nature. 2003 Jul 24;424(6947):456-61
12879076
J Gen Virol. 2008 Apr;89(Pt 4):853-865
18343825
J Gen Virol. 2006 Sep;87(Pt 9):2451-2460
16894182
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14118-23
18768787
Curr Top Microbiol Immunol. 2008;325:63-83
18637500
J Virol. 2004 May;78(9):4609-16
15078943
J Clin Virol. 2008 Mar;41(3):174-9
18203656
Biochem Biophys Res Commun. 1994 Feb 15;198(3):983-9
8117306
Arch Virol. 2006 Jun;151(6):1225-33
16380811
J Virol. 2003 Apr;77(8):4992-9
12663806
J Virol. 2004 Jul;78(14):7536-44
15220428
Virology. 1992 Nov;191(1):387-95
1329327
J Gen Virol. 2001 Jun;82(Pt 6):1429-1438
11369888
J Virol. 1998 Oct;72(10):8191-7
9733861